These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24015822)

  • 1. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
    Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
    J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.
    Bodhankar S; Chen Y; Lapato A; Vandenbark AA; Murphy SJ; Offner H
    Front Cell Neurosci; 2014; 8():228. PubMed ID: 25157219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation.
    Bodhankar S; Chen Y; Lapato A; Dotson AL; Wang J; Vandenbark AA; Saugstad JA; Offner H
    Stroke; 2015 Oct; 46(10):2926-34. PubMed ID: 26306753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.
    Ren X; Akiyoshi K; Vandenbark AA; Hurn PD; Offner H
    Stroke; 2011 Sep; 42(9):2578-83. PubMed ID: 21737801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
    Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
    Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice
    Offner H; Lockwood D; Meza-Romero R; Vandenbark AA
    Metab Brain Dis; 2023 Feb; 38(2):589-599. PubMed ID: 36454506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New expression of PD-L1 on activated CD4
    Mazerolles F
    Hum Immunol; 2024 Jul; 85(4):110831. PubMed ID: 38870593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
    Menke J; Lucas JA; Zeller GC; Keir ME; Huang XR; Tsuboi N; Mayadas TN; Lan HY; Sharpe AH; Kelley VR
    J Immunol; 2007 Dec; 179(11):7466-77. PubMed ID: 18025191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of STAT3-FOXO3 Signaling in the Modulation of Neuroplasticity by PD-L1-HGF-Decorated Mesenchymal Stem Cell-Derived Exosomes in a Murine Stroke Model.
    Lin SL; Chang YW; Lee W; Chiang CS; Liu SP; Lee HT; Jeng LB; Shyu WC
    Adv Sci (Weinh); 2024 Sep; 11(36):e2404882. PubMed ID: 39049677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 (Programmed Death Ligand 1) Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury.
    Han R; Luo J; Shi Y; Yao Y; Hao J
    Stroke; 2017 Aug; 48(8):2255-2262. PubMed ID: 28706113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.
    Neumann K; Ostmann A; Breda PC; Ochel A; Tacke F; Paust HJ; Panzer U; Tiegs G
    Sci Rep; 2019 Feb; 9(1):2038. PubMed ID: 30765734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells.
    Bodhankar S; Chen Y; Lapato A; Vandenbark AA; Murphy SJ; Saugstad JA; Offner H
    Metab Brain Dis; 2015 Aug; 30(4):911-924. PubMed ID: 25537181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke.
    Kim JE; Lee RP; Yazigi E; Atta L; Feghali J; Pant A; Jain A; Levitan I; Kim E; Patel K; Kannapadi N; Shah P; Bibic A; Hou Z; Caplan JM; Gonzalez LF; Huang J; Xu R; Fan J; Tyler B; Brem H; Boussiotis VA; Jantzie L; Robinson S; Koehler RC; Lim M; Tamargo RJ; Jackson CM
    Brain Behav Immun; 2024 Feb; 116():160-174. PubMed ID: 38070624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease.
    Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L
    Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.